Use of a once-daily NSAID in treatment of cyclic vomiting syndrome.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 24129856.
- Also identified by DOI 10.1007/s11606-013-2624-9 and PMC identifier 3930795.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Cyclic vomiting syndrome (CVS) is a rare disorder characterized by episodes of intense vomiting and nausea separated by symptom-free periods. We report the case of a 71-year-old man who presented with a long history of poorly controlled CVS whose symptoms resolved with the addition of a once-daily dose of meloxicam, a semi-selective non-steroidal anti-inflammatory drug (NSAID). This is the first report of symptom alleviation in a CVS patient using a once-daily NSAID, as well as one with selectivity to COX-2 inhibition. This is important due to both the increased compliance seen with once-daily medications, as well as the decreased gastrointestinal effects seen with selective COX-2 inhibitors compared to nonselective NSAIDS.
Medical subject headings
- Anti-Inflammatory Agents, Non-Steroidal
- Vomiting